Metastasis and hypoxia-inducible factor

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 11, 2010, Pages 2047-2051

  Kobayashi, Masanobu ^a,b   Nakagawa, Koji ^a,b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Acute hypoxia; Chronic hypoxia; HIF; Hypoxia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA;

BLOOD FLOW; CANCER CELL; CARCINOGENESIS; GENE EXPRESSION; HUMAN; HYPOXIA; METASTASIS; REVIEW; TUMOR MICROENVIRONMENT;

EID: 79961201861     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Becker A, Hänsgen G, Bloching M, et al: Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 42: 35-41, 1998. (Pubitemid 28435593)
2. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opini Cell Biol 13: 167-171, 2001.
3. Vaupel P: The role of hypoxia-inducible factors in tumor progression. Oncologist (suppl 5): 10-17, 2004.
4. Rankin ER and Giaccia AJ: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685, 2008.
5. Pugh CW, ORouke JF, Nagao M, et al: Activation of hypoxia-inducible factor-1: definition of regulatory domains within the alpha subunit. J Biol Chem 272: 11205-11214, 1997. (Pubitemid 27184117)
6. 2 homeostasis. Curr Opin Genet Dev 8: 588-594, 1998.
7. Warburg O: The Metabolism of Tumors. Richard R. Smith, Inc., New York, 1930, pp129-169.
8. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
9. Gardner LB and Corn PG: Hypoxic regulation of mRNA expression. Cell Cycle 7: 1916-1924, 2008.
10. Sullivan R and Graham CH: Hypoxia-driven selection of metastatic phenotype. Cancer Metastasis Rev 26: 319-331, 2007.
11. Chan DA and Giaccia AJ: Hypoxia, gene expression and metastasis. Cancer Metastasis Rev 26: 333-339, 2007.
12. Rofstad EK: Microenvironment-induced metastasis. Int J Radiat Biol 76: 589-605, 2000.
13. Subarsky P and Hill RP: The hypoxic tumor microenvironment and metastatic progression. Clin Exp Metastasis 20: 237-250, 2003. (Pubitemid 36513228)
14. Mirosevic M, Fyles A, Hedley D, et al: The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial pressure. Semin Radiat Oncol 14: 249-258, 2004. (Pubitemid 38903229)
15. Nordsmark M, Ericksen JG, Gevski V, et al: Differential risk assessment from five hypoxia specific assays; the basis for biologically adapted indivisualized radiotherapy in advanced head and neck cancer. Radiother Oncol 83: 389-397, 2007. (Pubitemid 46907981)
16. Cairns RA, Kalliomaki T and Hill RP: Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61: 8903-8908, 2001. (Pubitemid 34013907)
17. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 440: 1222-1226, 2006.
18. Erler JT, Bennewith KL, Nicholau M, et al: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226 2006.
19. Krishnamachary B, Berg-Dixon S, Kelly B, et al: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143, 2003. (Pubitemid 36278449)
20. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119-122, 1998.
21. Sundfor K, Lyng H and Rofstad EK: Tumoral hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 78: 822-827, 1998. (Pubitemid 28418321)
22. Young SD, Marshal RS and Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85: 9533-9537, 1988. (Pubitemid 19027161)
23. Rofstad EK and Danielsen T: Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br J Cancer 80: 1697-1707, 1999. (Pubitemid 29389621)
24. Thomlinson RH and Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539-549, 1955.
25. Bonitsis N, baitstatou A, Karantima S, et al: The role of cadherin/catenin complex in malignant melanoma. Exp Oncol 28: 187-193, 2006. (Pubitemid 44735907)
26. Bienz M: β-Catenin: a pivotal between cell adhesion and Wnt signaling. Curr Biol 15: R64-R67, 2005.
27. Chang Q, Qin R, Huang T, et al: Effect of antisense hypoxia-inducible factor 1 alpha on progression, metastasis, and chemosensitivity of pancreas cancer. Pancreas 32: 297-305, 2006.
28. Koike t, Kimura N, Miyazaki K, et al: Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA 101: 8132-8137, 2004.
29. Arao S, Matsumoto A, Otsuki MB, et al: Beta 1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells. Pancreas 20: 129-137, 2000. (Pubitemid 30123863)
30. Graham CH, Forsdike J, Fitzgerald CJ, et al: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80: 617-623, 1999. (Pubitemid 29047530)
31. Osisnsky SP, Ganusevich H, Bubonovskaya LN, et al: Hypoxia level and matrix metalloproteinase-2 and -9 activity in Lewis lung carcinoma correlation with metastasis. Exp Oncol 27: 202-205, 2005.
32. Rofstad EK, Rasmussen H, Galappathi K, et al: Hypoxia promotes lymph node metastasis in human melanoma xenografts by upregulating the urokinase-type plasminogen activator receptor. Cancer Res 62: 1847-1853, 2002.
33. Erler JT and Giaccia AJ: Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 66: 10238-10241, 2006. (Pubitemid 44799737)
34. Zhu Y, Denhardt DT, Gao H, et al: Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene 24: 6555-6563, 2005. (Pubitemid 41486638)
35. Wai PY and Kuo PC: The role of osteopontin in tumor metastasis. J Surg Res 121: 228-241, 2004.
36. Tuck AB, Arsenault DM, O'Malley PP, et al: Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary carcinomas. Arch Pathol Lab Med 121: 578-584, 1997.
37. Thalman GN, Sikes RA, Devoll RE, et al: Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5: 2271-2277, 1999. (Pubitemid 29399287)
38. Agrawal D, Chen T, Irby R, et al: Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profile. J Natl Cancer Inst 94: 513-521, 2002.
39. Overgaard J, Erickson JG, Nordsmark M, et al: Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimodazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomized double-blind placebo-controlled trial. Lancet Oncol 6: 757-764, 2005. (Pubitemid 41430716)
40. Bramwell VH, Tuck AB, Wilson SM, et al: Expression of osteopontin and HGF/met in adult soft tissue tumors. Cancer Biol Ther 4: 1336-1341, 2005. (Pubitemid 43131177)
41. Le QT, Sutphin PD, Raychaudhuri S, et al: Identification of osteopontin as a prognostic plasma marker for head and neck cancer. Clin Cancer Res 9: 59-67, 2003. (Pubitemid 36109716)
42. Muller A, Nomey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
43. Pan J, Mestas J, Burdick MD, et al: Stromal derived factor-1 (SDF-1/CXCl12) and CXCR4 in renal carcinoma metastasis. Mol Cancer 5: 56-69, 2006.
44. Niizeki H, Kobayashi M, Akakura N, et al: Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer 86: 1914-1919, 2002.
45. Funasaka T, Yanagawa T, Hogan V, et al: Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 19: 1422-1430, 2005. (Pubitemid 41279000)